written on 25.03.2014
pt:
Tags:
,

UPDATED: AbbVie CEO's pay doubles to $18.2M in Abbott pharma spinoff's first solo year

TAGS: ,

AbbVie CEO Richard Gonzalez has been on the job for just over a year, and already his pay has more than doubled. As chief of the newly minted pharma company, spun off from Abbott Laboratories last January 1, Gonzalez racked up $18.2 million in 2013 compensation, including $3.3 million in incentive pay.

Latest Report